IPO and Capital Markets

IPO and Capital Markets Practice

Our Corporate & Commercial Advisory and Mergers, Acquisitions & PE/VC practices manage the full legal process for companies preparing for a public listing in India — from pre-IPO structuring and governance audit through legal due diligence, DRHP preparation, the SEBI query cycle, and post-listing LODR compliance.

  • We advise that IPO legal preparation begins eighteen months to two years before the anticipated listing — not at the DRHP filing stage. Pre-filing is where governance restructuring, documentation completion, and IP ownership confirmation happen.
  • Our IP Audits & Valuation and IP Licensing & Commercialisation practices integrate directly into our IPO due diligence — addressing trademark, patent, and design ownership gaps that are among the most common material findings in SEBI-regulated offer documents.
  • We prepare DRHPs to be complete and fully responsive to the ICDR Regulations at first filing — DRHP quality at first filing determines the length of SEBI’s query cycle.
  • Post-listing obligations under SEBI’s LODR Regulations are significantly more demanding than pre-listing compliance. We brief boards on these obligations before listing day, not after.
  • As an Advocate-on-Record with the Supreme Court of India, our Dispute Resolution practice handles post-listing disputes and appellate proceedings without change of counsel.
  1. The Regulatory Framework

    We work within four primary regulatory frameworks in every Indian IPO: the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (ICDR Regulations); the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations); the Companies Act, 2013; and FEMA 1999 for companies with non-resident shareholders.

  2. Pre-IPO Eligibility Assessment and Structuring

    We conduct a formal eligibility assessment before any DRHP filing, verifying compliance with Regulation 6 of the ICDR Regulations — net tangible assets threshold, operating profit history, and net worth requirements for the standard profitability route, or the conditions applicable to the alternative route. Our pre-filing assessment regularly identifies structural issues: conversion from private to public limited company; group company reorganisation; related-party transactions requiring arm’s-length restructuring; historical capital allotments requiring regularisation; and board composition review against SEBI’s independence criteria.

    “Companies that begin IPO legal preparation eighteen months before the anticipated listing quietly resolve historical gaps. Those that begin at the DRHP filing stage resolve them under time pressure, at greater cost, and with less control over how they are disclosed.”
  3. Legal Due Diligence — Our Six Workstreams

    We conduct IPO legal due diligence across six workstreams: corporate records and promoter group; material contracts and assignability; IP ownership and registration across territories; litigation and regulatory proceedings; real property title; and employment and labour compliance. Our IP Audits & Valuation team integrates directly — because unassigned trademarks, patents held in founders’ personal names, and software licensed on inconsistent terms are among the most common and most avoidable material findings in SEBI-regulated offer documents.

  4. DRHP Preparation and the SEBI Review Cycle

    We prepare the DRHP in coordination with the BRLMs, their counsel, reporting accountants, and management. We prepare specific, calibrated risk factor disclosures for this company and this offering — not boilerplate descriptions of generic market risks. DRHPs that are complete and fully responsive to the ICDR Regulations at first filing move through SEBI’s query cycle significantly faster than those that do not.

  5. Pricing, Book Building, and Allotment

    Once SEBI issues its final observations, we manage the red herring prospectus filing, the subscription period, and the allotment process. We advise on the SEBI-prescribed allotment proportions to QIBs, non-institutional investors, and retail individual investors, and manage the basis of allotment process with the registrar to the issue.

  6. Post-Listing Obligations — What We Manage

    We advise listed companies on their ongoing obligations under SEBI’s LODR Regulations: continuous disclosure of material events; quarterly and annual financial reporting; audit committee review and shareholder approval of material related-party transactions; and the insider trading framework under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Our Corporate & Commercial Advisory, IP Audits & Valuation, and Dispute Resolution practices work as a coordinated team. Ranked by IAM Patent 1000, Chambers & Partners, and Legal 500, we advise from offices in New Delhi, Mumbai, Chennai, Hyderabad, and Bangalore.

Frequently Asked Questions

ipo-and-capital-markets-practice-faq

We advise starting eighteen months to two years before the anticipated listing. The pre-filing phase is where governance restructuring, documentation completion, and IP ownership confirmation happen. Companies that start at the DRHP filing stage resolve historical gaps under time pressure, at greater cost, and with less control over disclosure.

SEBI’s ICDR Regulations prescribe two principal routes. The standard profitability track record route requires minimum net tangible assets, operating profit history over specified preceding years, and a minimum net worth. An alternative route is available for companies without the required track record, subject to specified conditions relating to institutional investor allocation. These thresholds are subject to amendment and must be verified against the current text of the Regulations before any determination.

IPO legal due diligence covers corporate records and cap table, material contracts and their assignability on a listing event, IP ownership and registration status, pending and threatened litigation and regulatory proceedings, real property title, and employment and labour compliance. The BRLMs’ lawyers also conduct their own independent exercise. IP due diligence is particularly critical for technology, pharmaceutical, and consumer brand issuers.

The DRHP-to-listing timeline is typically six to twelve months from filing. SEBI’s review involves written observations to which the issuer must respond within prescribed timelines. Issuers whose DRHPs are complete and responsive to the ICDR Regulations at first filing move through this cycle significantly faster than those where the filing is used to open a negotiation on disclosure scope.

Under SEBI’s LODR Regulations, 2015, a listed company must make continuous disclosure of material events immediately upon occurrence, publish quarterly and annual financial results within prescribed timelines, obtain audit committee and shareholder approval for related-party transactions above specified thresholds, and comply with the SEBI (Prohibition of Insider Trading) Regulations, 2015 regarding trading windows, pre-clearance, and UPSI database management.

For technology, pharmaceutical, and consumer brand companies, IP is a material asset that receives close scrutiny in the offer document. Unassigned trademarks filed in a founder’s personal name, patents held by inventors without a formal assignment to the company, and software licensed on terms inconsistent with the company’s intended scale are recurring material findings that create disclosure risk and can delay closing.

For more information please contact us at : info@ssrana.com